Literature DB >> 27835802

Transient Receptor Potential Channels in neuropathic pain.

Lilian Basso1, Christophe Altier2.   

Abstract

Neuropathic pain caused by disease or dysfunction of the nervous system is one of the most difficult pain conditions to treat. Symptoms include a hypersensitivity to mechanical and thermal stimuli, processed by specialized nociceptors that constitute the first line of defence of the somatosensory system. The detection of these stimuli depends on the TRP ion channel family, which activates upon damaging pressure, extreme temperature, or toxic endogenous and exogenous chemicals. This review will summarize the current knowledge of the contribution of TRP channels, particularly the thermosensitive TRP, including TRPV1, TRPA1 and TRPM8 channels that play a central role in the sensitization of nociceptive transduction. We will discuss the pharmacology of these receptors and their relative success in preclinical and clinical studies.
Copyright © 2016 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27835802     DOI: 10.1016/j.coph.2016.10.002

Source DB:  PubMed          Journal:  Curr Opin Pharmacol        ISSN: 1471-4892            Impact factor:   5.547


  33 in total

1.  TRPV1-Targeted Drugs in Development for Human Pain Conditions.

Authors:  Mircea Iftinca; Manon Defaye; Christophe Altier
Journal:  Drugs       Date:  2021-01       Impact factor: 9.546

2.  Role of TRPM8 Channels in Altered Cold Sensitivity of Corneal Primary Sensory Neurons Induced by Axonal Damage.

Authors:  Ricardo Piña; Gonzalo Ugarte; Matías Campos; Almudena Íñigo-Portugués; Erick Olivares; Patricio Orio; Carlos Belmonte; Juan Bacigalupo; Rodolfo Madrid
Journal:  J Neurosci       Date:  2019-08-30       Impact factor: 6.167

3.  Molecular mechanisms of the analgesic action of Wu-tou Decoction on neuropathic pain in mice revealed using microarray and network analysis.

Authors:  Yan-Qiong Zhang; Chao Wang; Qiu-Yan Guo; Chun-Yan Zhu; Chen Yan; Dan-Ni Sun; Qiong-Hong Xu; Na Lin
Journal:  Acta Pharmacol Sin       Date:  2017-08-17       Impact factor: 6.150

4.  Targeting Neuroimmune Interactions in Diabetic Neuropathy with Nanomedicine.

Authors:  Mihály Balogh; Jelena M Janjic; Andrew J Shepherd
Journal:  Antioxid Redox Signal       Date:  2022-01       Impact factor: 8.401

5.  Peripheral Ion Channel Gene Screening in Painful- and Painless-Diabetic Neuropathy.

Authors:  Milena Ślęczkowska; Rowida Almomani; Margherita Marchi; Bianca T A de Greef; Maurice Sopacua; Janneke G J Hoeijmakers; Patrick Lindsey; Erika Salvi; Gidon J Bönhof; Dan Ziegler; Rayaz A Malik; Stephen G Waxman; Giuseppe Lauria; Catharina G Faber; Hubert J M Smeets; Monique M Gerrits
Journal:  Int J Mol Sci       Date:  2022-06-28       Impact factor: 6.208

6.  Facilitation of MrgprD by TRP-A1 promotes neuropathic pain.

Authors:  Changming Wang; Leying Gu; Yonglan Ruan; Xiao Geng; Miao Xu; Niuniu Yang; Lei Yu; Yucui Jiang; Chan Zhu; Yan Yang; Yuan Zhou; Xiaowei Guan; Wenqin Luo; Qin Liu; Xinzhong Dong; Guang Yu; Lei Lan; Zongxiang Tang
Journal:  FASEB J       Date:  2018-08-27       Impact factor: 5.191

7.  Lysophospholipids Contribute to Oxaliplatin-Induced Acute Peripheral Pain.

Authors:  Vittoria Rimola; Lisa Hahnefeld; Junli Zhao; Changyu Jiang; Carlo Angioni; Yannick Schreiber; Tabea Osthues; Sandra Pierre; Gerd Geisslinger; Ru-Rong Ji; Klaus Scholich; Marco Sisignano
Journal:  J Neurosci       Date:  2020-11-06       Impact factor: 6.167

Review 8.  Cutaneous pain in disorders affecting peripheral nerves.

Authors:  Cheryl L Stucky; Alexander R Mikesell
Journal:  Neurosci Lett       Date:  2021-10-01       Impact factor: 3.046

Review 9.  Development of TRPM8 Antagonists to Treat Chronic Pain and Migraine.

Authors:  Andy D Weyer; Sonya G Lehto
Journal:  Pharmaceuticals (Basel)       Date:  2017-03-30

Review 10.  Uncovering the Cells and Circuits of Touch in Normal and Pathological Settings.

Authors:  Francie Moehring; Priyabrata Halder; Rebecca P Seal; Cheryl L Stucky
Journal:  Neuron       Date:  2018-10-24       Impact factor: 17.173

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.